Search Results - "Logan AC"

Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression.

Authors: Logan AC (AUTHOR)

Source: Alternative Medicine Review. Nov2003, Vol. 8 Issue 4, p410-425. 16p.

URL: 11610449

Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer.

Authors: Riess JW Logan AC Krupitskaya Y et al.

Source: Cancer Investigation. Mar2012, Vol. 30 Issue 3, p231-235. 5p.

Dietary fiber, mood, and behavior.

Authors: Logan AC (AUTHOR)

Source: Nutrition. Feb2006, Vol. 22 Issue 2, p213-214. 2p.

Challenging the prescientific frameworks of criminal justice: neurobiology and criminolytic interventions in the legalome era.

Authors: Logan AC Mishra P Berryessa CM et al.

Source: Frontiers in psychology [Front Psychol] 2026 Apr 16; Vol. 17, pp. 1791262. Date of Electronic Publication: 2026 Apr 16 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101550902 Publication Model: eCollection Cited Medium: Print ISSN: 1664-1078 (Print) Linking ISSN: 16641078 NLM ISO Abbreviation: Front Psychol Subsets: PubMed not MEDLINE

The gut is guilty! Will legalomics transform forensic and legal psychology?

Authors: Mishra P Prescott SL Logan AC

Source: Frontiers in psychology [Front Psychol] 2026 Mar 18; Vol. 17, pp. 1739593. Date of Electronic Publication: 2026 Mar 18 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101550902 Publication Model: eCollection Cited Medium: Print ISSN: 1664-1078 (Print) Linking ISSN: 16641078 NLM ISO Abbreviation: Front Psychol Subsets: PubMed not MEDLINE

The Metabolic Mind: Revisiting Glucose Metabolism and Justice Involvement in Neurolaw.

Authors: Logan AC Berryessa CM Greeson JM et al.

Source: NeuroSci [NeuroSci] 2025 Nov 24; Vol. 6 (4). Date of Electronic Publication: 2025 Nov 24.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101772310 Publication Model: Electronic Cited Medium: Internet ISSN: 2673-4087 (Electronic) Linking ISSN: 26734087 NLM ISO Abbreviation: NeuroSci Subsets: PubMed not MEDLINE

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

Authors: Othman T Roloff GW Miller K et al.

Source: Blood advances [Blood Adv] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

Authors: Roddie C Day W Raymond M et al.

Source: Cancer research communications [Cancer Res Commun] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Authors: Jabbour E Sandhu KS Shaughnessy P et al.

Source: Haematologica [Haematologica] 2026 Jun 01; Vol. 111 (6), pp. 1999-2010. Date of Electronic Publication: 2026 Jan 08.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Consensus Recommendations for CAR T-Cell Administration in Adult Acute Lymphoblastic Leukemia: a Modified Delphi Study.

Authors: Muffly L Frey NV Roloff GW et al.

Source: Blood [Blood] 2026 May 19. Date of Electronic Publication: 2026 May 19.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Authors: Srinagesh HK Gupta V Zhang A et al.

Source: Blood [Blood] 2026 Apr 23; Vol. 147 (17), pp. 2011-2017.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

A unified theory of restrictive and addictive eating: a life course model integrating generational transmission, neurodevelopmental risk, and ultra-processed food use disorder-a theoretical review.

Authors: Wiss DA Logan AC

Source: Journal of eating disorders [J Eat Disord] 2026 Apr 21; Vol. 14 (1). Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101610672 Publication Model: Electronic Cited Medium: Print ISSN: 2050-2974 (Print) Linking ISSN: 20502974 NLM ISO Abbreviation: J Eat Disord Subsets: PubMed not MEDLINE

Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.

Authors: Othman T Lo MM Andreadis CB et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Sep; Vol. 66 (9), pp. 1749-1752. Date of Electronic Publication: 2025 May 07.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

The Big Minority View: Do Prescientific Beliefs Underpin Criminal Justice Cruelty, and Is the Public Health Quarantine Model a Remedy?

Authors: Logan AC Prescott SL

Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2025 Jul 24; Vol. 22 (8). Date of Electronic Publication: 2025 Jul 24.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE

Commentary: Propionimicrobium lymphophilum in urine of children with monosymptomatic nocturnal enuresis.

Authors: Prescott SL Logan AC

Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2025 Apr 07; Vol. 15, pp. 1553911. Date of Electronic Publication: 2025 Apr 07 (Print Publication: 2025).

Publication Type: Journal Article; Comment

Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE; In Process

CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.

Authors: Oliai C Park S Damon LE et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Apr; Vol. 66 (4), pp. 773-779. Date of Electronic Publication: 2024 Dec 17.

Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase I

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Transportability to the European Population of Efficacy of Belumosudil as Compared With Physician's Choice of Best Available Therapy for the Treatment of Chronic Graft Versus Host Disease.

Authors: Wolff D Solano C Michonneau D et al.

Corporate Authors: Wolff D Solano C Michonneau D et al.

Source: Transplantation and cellular therapy [Transplant Cell Ther] 2026 Mar 25. Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Efficacy and safety of belumosudil as compared with best available therapy for the treatment of cGVHD in the United States.

Authors: Hall K Lazaryan A van der Laan M et al.

Source: Blood advances [Blood Adv] 2026 Feb 10; Vol. 10 (3), pp. 682-693.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML.

Authors: Popescu B Jones MF Piao M et al.

Source: Blood [Blood] 2026 Jan 15; Vol. 147 (3), pp. 276-289.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Authors: Valtis YK Lin C Nemirovsky D et al.

Source: Blood advances [Blood Adv] 2026 Jan 13; Vol. 10 (1), pp. 276-288.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE